Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung
2,000 individuals, aged 50-80 who have received a lung-RADS category 3 or 4 result on a LDCT screening study and who are scheduled for follow-up diagnostic imaging study, biopsy, clinical consultation or surgical appointment at one of the participating hospitals.
Checked against the public recordLast updated Jan 16, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Hummingbird Diagnostics
- Interventions being studied
- Diagnostic Test: miLungDx
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Adult male and female patients, aged 50 to 80 years * Received a lung RADS category 3 or 4 finding on a LDCT screening exam (first or subsequent) and are referred to undergo further diagnostic procedures for the detection of lung cancer * Has undergone LD-CT screening exam within last 90 days and allows for blood sampling within this period * Subject may not have undergone any invasive diagnostic procedure in relation to the suspicious nodule * Able and willing to provide informed consent Exclusion Criteria: * Prior history of diagnosed lung cancer * History of gastrointestinal, hematological, breast, thyroid, and genitourinary cancer within the past 10 years * Active infectious diseases, such blood borne viral diseases (e.g. AIDS, hepatitis) * Immunosuppressive medication * Deemed not able to participate in the study by the investigator
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Northside HospitalAtlanta, Georgia
- Mass General BrighamBoston, Massachusetts
- Henry Ford HealthDetroit, Michigan
- Jacobi Medical CenterThe Bronx, New York
- New York Health + HospitalsThe Bronx, New York
- Duke University Health SystemDurham, North Carolina
- Baptist Hospitals of Southeast TexasBeaumont, Texas
- University Of Utah HealthSalt Lake City, Utah
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 16, 2024. Always confirm current availability with the study team.